Lipo-B is generally well-tolerated in the clinical context in which it is prescribed. A medical assessment is required before a prescription is issued.
Lipo-B is not for use in patients who have cancer, a history of cancer, or who are pregnant or breastfeeding.
Pregnancy and Breastfeeding Strictly contraindicated for these populations due to a complete lack of clinical safety data regarding fetal development and maternal hormone stability.
Pediatric Use This product is not recommended for children or adolescents.
With GLP-1 Receptor Agonists (Semaglutide / Tirzepatide) GLP-1 agonists facilitate weight loss by slowing digestion and reducing appetite, which can sometimes lead to fatigue or "sluggish" liver processing of mobilized fat. Lipo-B facilitates the energy surge needed to combat "GLP-1 fatigue" and provides the MIC nutrients necessary for the liver to process the high volume of fats being released. This combination facilitates a smoother weight loss curve with fewer side effects.
With NAD+ NAD+ facilitates mitochondrial repair and DNA protection. Lipo-B provides the B-vitamin co-factors required for the mitochondria to actually produce energy (ATP). Using them together facilitates a "doubling up" of cellular efficiency.
Discuss all current medications with your prescribing provider.
A medical assessment is required before Lipo-B is prescribed. Your provider will review your health history, current medications, and indication to confirm Lipo-B is appropriate for you.